NEW YORK: US blue chips climbed for the fourth day in a row on Friday, but gains were capped by another surge in oil prices while economic reports cast doubt on the economy’s strength.
Meanwhile, strong earnings from Gilead Sciences Inc helped push up the Nasdaq, after the biotechnology company reported a higher quarterly net profit on increased sales of its flagship HIV drug.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!